Genomic alterations are well-described in Barrett oesophagus and its sequela, oesophageal adenocarcinoma, but epigenomic events have not been so widely investigated. In a new study, Jammula et al. analysed the DNA methylation profiles of Barrett oesophagus, oesophageal adenocarcinoma and control tissues. Four molecular subtypes were identified, revealing four distinct epigenomic classes and potential therapeutic targets.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Jin, Z. et al. A multicenter, double-blinded validation study of methylation biomarkers for progression prediction in Barrett’s esophagus. Cancer Res. 69, 4112–4115 (2009).
Agarwal, R. et al. Epigenomic program of Barrett’s-associated neoplastic progression reveals possible involvement of insulin signaling pathways. Endocr. Relat. Cancer 19, L5–9 (2012).
Jammula, S. et al. Identification of subtypes of Barrett’s esophagus and esophageal adenocarcinoma based on DNA methylation profiles and integration of transcriptome and genome data. Gastroenterology https://doi.org/10.1053/j.gastro.2020.01.044 (2020).
Akagi, T. et al. Chromosomal abnormalities and novel disease-related regions in progression from Barrett’s esophagus to esophageal adenocarcinoma. Int. J. Cancer 125, 2349–2359 (2009).
Wu, W. et al. Hypomethylation of noncoding DNA regions and overexpression of the long noncoding RNA, AFAP1-AS1, in Barrett’s esophagus and esophageal adenocarcinoma. Gastroenterology 144, 956–966 (2013).
Alvarez, H. et al. Widespread hypomethylation occurs early and synergizes with gene amplification during esophageal carcinogenesis. PLoS Genet. 7, e1001356 (2011).
Chen, L. et al. Master transcription factors form interconnected circuitry and orchestrate transcriptional networks in oesophageal adenocarcinoma. Gut 69, 630–640 (2020).
Agrawal, N. et al. Comparative genomic analysis of esophageal adenocarcinoma and squamous cell carcinoma. Cancer Discov. 2, 899–905 (2012).
Dulak, A. M. et al. Exome and whole-genome sequencing of esophageal adenocarcinoma identifies recurrent driver events and mutational complexity. Nat. Genet. 45, 478–486 (2013).
Cancer Genome Atlas Research Network. et al. Integrated genomic characterization of oesophageal carcinoma. Nature 541, 169–175 (2017).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
S.J.M. owns partial equity and patent rights in Capsulomics, Inc. This interest is not directly relevant to the topic of this manuscript.
Rights and permissions
About this article
Cite this article
Meltzer, S.J. Molecular epigenomic subtypes of Barrett neoplasia. Nat Rev Gastroenterol Hepatol 17, 261–262 (2020). https://doi.org/10.1038/s41575-020-0292-x
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41575-020-0292-x
